Medical Devices industry M&A deals total $3bn globally in October 2021

Total medical devices industry M&A deals worth $3bn were announced globally in October 2021, led by Boston Scientific’s $1.75bn acquisition of Baylis MedicalInc, according to GlobalData’s deals database.

The value marked a decrease of 5.6% over the previous month of $3.22bn and a drop of 40.5% when compared with the last 12-month average, which stood at $5.11bn.

Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $2.72bn. At the country level, the Canada topped the list in terms of deal value at $1.75bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in October 2021 was the US with 15 deals, followed by the China with three and France with three.

In 2021, as of October, medical devices M&A deals worth $51.62bn were announced globally, marking an increase of 28.3% year on year.

medical devices industry M&A deals in October 2021: Top deals

The top five M&A deals accounted for 87.8% of the overall value during October 2021.

The combined value of the top five medical devices M&A deals stood at $2.67bn, against the overall value of $3bn recorded for the month.

The top five medical devices industry M&A deals of October 2021 tracked by GlobalData were:

1) Boston Scientific $1.75bn acquisition deal with Baylis Medical Inc

2) The $400m acquisition of Volumetric by 3D Systems

3) Integer $220m acquisition deal with Oscor

4) The $160m acquisition of Bolder Surgical by Hologic

5) MicroPort Surgical $142.6m acquisition deal with Hemovent